2012)
- Brown J.B, Niijima S, Shiraishi A, Nakatsui M, Okuno Y. “Chemogenomic approach to comprehensive predictions of ligand-target interactions: A comparative study” IEEE International Conference on Bioinformatics and Biomedicine (BIBM) Workshop on Pharmaco-informatics for Drug Discovery (PIDD). 2012:136-142. Available from: https://doi.org/10.1109/BIBMW.2012.6470295
- Niijima S, Shiraishi A, Okuno Y. “Dissecting kinase profiling data to predict activity and understand cross-reactivity of kinase inhibitors” J. Chem. Inf. Model. 2012;52:901-912. Available from: https://doi.org/10.1021/ci200607f
- Fazekas S.Z, Ito H, Okuno Y, Seki S, Taneishi K. “On computational complexity of graph inference from counting” Nat Comput. 2012;12:589-603. Available from: https://doi.org/10.1007/s11047-012-9349-2
- Tamura T, Sakaeda T, Kadoyama K, Okuno Y. “Aspirin- and clopidogrel-associated bleeding complications: Data mining of the public version of the FDA adverse event reporting system, AERS” Int. J. Med. Sci. 2012;9:441-446. Available from: https://doi.org/10.7150/ijms.4549
- Tamura T, Sakaeda T, Kadoyama K, Okuno Y. “Omeprazole- and esomeprazole-associated hypomagnesaemia: Data mining of the public version of the FDA adverse event reporting system” Int. J. Med. Sci. 2012;9:322-326. Available from: https://dx.doi.org/10.7150%2Fijms.4397
- Kadoyama K, Sakaeda T, Tamon A, Okuno Y. “Adverse event profile of tigecycline: Data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system” Biol. Pharm. Bull. 2012;35:967-970. Available from: https://doi.org/10.1248/bpb.35.967
- Minowa Y, Kondo C, Uehara T, Morikawa Y, Okuno Y, Nakatsu N, Ono A, Maruyama T, Kato I, Yamate J, Yamada H, Ohno Y, Urushidani T. “Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats” Toxicology 2012;297:47-56. Available from: https://doi.org/10.1016/j.tox.2012.03.014
- Sakaeda T, Kadoyama K, Okuno Y. “Statin-associated Muscular and Renal Adverse Events: Data mining of the public version of the FDA adverse event reporting system” PLoS ONE. 2011;6(12):e28124. Available from: https://doi.org/10.1371/journal.pone.0028124
- Katoh-Fukui Y, Miyabayashi K, Komatsu T, Owaki A, Baba T, Shima Y, Kidokoro T, Kanai Y, Schedl A, Wilhelm D, Koopman P, Okuno Y, Morohashi K. “Cbx2, a polycomb group gene, is required for sry gene expression in mice” Endocrinology. 2012;153(2):913-24. Available from: https://doi.org/10.1210/en.2011-1055
- Kadoyama K, Miki I, Tamura T, Brown J.B, Sakaeda T, Okuno Y. “Adverse event profiles of 5-fluorouracil and capecitabine: Data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations” Int. J. Med. Sci. 2012;9:33-39. Available from: https://doi.org/10.7150/ijms.9.33
